A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity? (Q39027143)

8 September 2017

title

A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity? (English)

1 reference

8 September 2017

Grace Patlewicz

2

0 references

Ovanes G Mekenyan

9

object named as

Ovanes G Mekenyan

1 reference

8 September 2017

Petko I Petkov

1

1 reference

8 September 2017

Terry W Schultz

3

1 reference

8 September 2017

Masamitsu Honma

4

1 reference

8 September 2017

Milen Todorov

5

1 reference

8 September 2017

Stefan Kotov

6

1 reference

8 September 2017

Sabcho D Dimitrov

7

1 reference

8 September 2017

E Maria Donner

8

1 reference

8 September 2017

language of work or name

English

0 references

publication date

16 March 2015

1 reference

Regulatory Toxicology and Pharmacology

8 September 2017

published in

1 reference

8 September 2017

volume

72

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

17-25

1 reference

Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Structural analysis and predictive value of the rodent in vivo micronucleus assay results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

IARC classes 1 and 2 carcinogens are successfully identified by an alternative strategy that detects DNA-reactivity and cell transformation ability of chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

7 January 2021

The mouse lymphoma assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

The comet assay for DNA damage and repair: principles, applications, and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Proposed integrated decision-tree testing strategies for mutagenicity and carcinogenicity in relation to the EU REACH legislation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Genotoxicity risk assessment: a proposed classification strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Current status of bioassays in genetic toxicology--the dominant lethal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Integrated testing strategies for use in the EU REACH system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Detailed review of transgenic rodent mutation assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Investigating the relationship between in vitro-in vivo genotoxicity: derivation of mechanistic QSAR models for in vivo liver genotoxicity and in vivo bone marrow micronucleus formation which encompass metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

The Ames Salmonella/microsome mutagenicity assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Recent advances in the protocols of transgenic mouse mutation assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

The comet assay: a method to measure DNA damage in individual cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2015.03.003

10.1016/J.YRTPH.2015.03.003

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference